As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
Webinar on The Most Common Issues in Preparing SEND: Explained
In this webinar, we discussed how SEND-ASSURE ensures consistency with the audited Study Report, conformance to Technical Rejection Criteria guidelines, and... read more
Refreshing Clinical Data Validation for Modern BioPharma
Validation and study data quality should be thought of as iterative and continuous workflows. Yet, many teams still work... read more
100% Consistency Check of SEND Datasets Against NCSR
March 17th, 2020 read more
Taking full advantage of the SEND data potential
Jointly published by Roche and PointCross Lifesciences read more
